Welcome to our dedicated page for Amrize SEC filings (Ticker: AMRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amrize Ltd filings document a Swiss-incorporated North American building-solutions company with ordinary shares listed on the New York Stock Exchange and SIX Swiss Exchange. The company’s SEC reports include Form 8-K disclosures for quarterly and annual financial results, Regulation FD investor materials, dividend-related events, auditor changes, and board or executive appointments.
Proxy and annual meeting filings cover shareholder voting, board elections, compensation matters, distributions from legal reserves from capital contributions, and governance procedures under the company’s Swiss corporate structure. The filing record also documents Amrize’s completed spin-off from Holcim and related public-company reporting matters.
Amrize Ltd reported a mine safety incident at its Ravena cement plant in New York. On January 15, 2026, the company received an imminent danger order from the Mine Safety and Health Administration under Section 107(a) of the Federal Mine Safety and Health Act of 1977.
The order related to a third-party dump trailer driver who was exposed to a fall hazard while standing on the ladder rungs of a vehicle trailer. The company states that no injuries occurred as a result of this incident.
BlackRock, Inc. filed Amendment No. 2 to a Schedule 13G reporting beneficial ownership of 19,887,938 shares of Amrize Ltd common stock, representing 3.6% of the outstanding class as of the reporting date. BlackRock reports sole voting power over 18,280,793 shares and sole dispositive power over 19,887,938 shares, with no shared voting or dispositive power.
The filing reflects holdings by certain BlackRock business units and excludes any disaggregated units under SEC guidance. Various underlying persons may receive dividends or sale proceeds from these shares, but no single person has more than 5% of Amrize’s outstanding common stock. BlackRock certifies the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Amrize.
Amrize Ltd (AMRZ) director share purchase disclosed. A reporting person serving as a director of Amrize Ltd bought 2,000 ordinary shares on 11/19/2025 at a price of $47.34 per share in an open-market purchase coded "P." After this transaction, the director beneficially owns 4,958 ordinary shares held directly. The filing does not report any transactions in derivative securities.
Amrize Ltd (AMRZ) reported an insider purchase. An officer, President, Building Materials, acquired 4,000 ordinary shares on 11/04/2025 at $50.685 per share.
Following the transaction, the insider beneficially owned 18,101 shares, held directly. The filing was made by one reporting person on a Form 4.
Amrize Ltd (AMRZ) disclosed a Form 4 showing its Chief Technology Officer purchased a total of 4,000 ordinary shares on 10/31/2025 across two open‑market trades at $51.78 (3,000 shares) and $51.76 (1,000 shares). Following these transactions, the officer directly holds 9,000 shares.
The filing notes the trades were executed in Swiss Francs at CHF 41.51 and CHF 41.50 per share, converted using the transaction‑date exchange rate of USD 1.00 = CHF 0.8017.
Amrize Ltd (AMRZ) insider activity: On 10/30/2025, the company’s Chairman & CEO, who is also a Director, reported two open‑market purchases (Transaction Code P): 55,000 ordinary shares at a weighted average price of $52.64 (converted from CHF 42.05) and 55,000 ordinary shares at a weighted average price of $52.88. The purchases were executed in multiple trades within the stated price ranges.
Following these transactions, beneficial ownership was 1,505,000 shares held directly and 505,000 shares held indirectly by spouse.
Amrize Ltd and its subsidiary Amrize Finance US LLC filed a Form S-4 to register exchange offers for $5,204,174,000 aggregate principal amount of senior notes. Holders may exchange their outstanding initial notes for new exchange notes with substantially identical terms, except the exchange notes are registered and do not carry Holcim Ltd guarantees.
The series include 3.500% due 2026, 4.600% due 2027, 4.700% due 2028, 4.950% due 2030, 4.200% due 2033, 5.400% due 2035, 7.125% due 2036, 6.875% due 2039, 6.500% due 2043 and 4.750% due 2046. The notes are senior unsecured obligations of the issuer and are guaranteed on a senior unsecured basis by Amrize Ltd. The filing states the exchange offers are made to satisfy registration rights agreements and will not generate cash proceeds.
Amrize became an independent public company following Holcim’s spin-off on June 23, 2025. Exchanging initial notes for exchange notes is not a taxable event for U.S. federal income tax purposes. Broker-dealers receiving exchange notes for market-making activities must deliver a prospectus when reselling.
The Vanguard Group filed a Schedule 13G reporting a passive stake in Amrize Ltd. Vanguard disclosed beneficial ownership of 30,094,083 shares of common stock, representing 5.3% of the class as of 09/30/2025. The filing lists 0 shares with sole voting power and 7,449,100 with shared voting power, along with 20,520,828 shares under sole dispositive power and 9,573,255 under shared dispositive power.
Vanguard certified the securities were acquired and are held in the ordinary course of business and not to change or influence control. The firm is identified as an investment adviser. Vanguard’s clients, including registered investment companies and other managed accounts, may receive dividends or sale proceeds tied to these securities, and no single other person’s interest exceeds 5%.
Amrize Ltd (AMRZ) reported Q3 2025 results. Revenue rose to $3,675 million from $3,446 million, while diluted EPS was $0.98 versus $1.00 a year ago. Gross profit improved to $1,086 million, but operating income declined to $778 million as selling, general and administrative expenses increased to $312 million.
By segment, Building Materials revenue was $2,774 million with Segment Adjusted EBITDA of $902 million, and Building Envelope revenue was $901 million with Segment Adjusted EBITDA of $217 million. For the first nine months, revenue was $8,976 million and diluted EPS was $1.60.
Following its June 2025 spin-off from Holcim, Amrize reshaped its capital structure: long-term debt was $4,932 million, including new senior notes issued earlier in 2025 and exchanged notes, and commercial paper outstanding of $547 million. Cash and cash equivalents were $826 million. Operating cash flow for the nine months was $404 million, with capital expenditures of $631 million. Shares outstanding were 553,082,069 as of September 30, 2025.
Amrize Ltd furnished an 8-K announcing it issued a press release with financial results for the quarter ended September 30, 2025, and an investor presentation. The materials are furnished under Items 2.02 and 7.01 and made available as Exhibits 99.1 and 99.2, dated October 28, 2025.
The company notes these materials are furnished, not filed, under the Exchange Act and are available on its investor website.